EU MRV Regulation - KYMA’s Solution

Operationalising MRV of Support

REGULATION AND STATE OWNERSHIP: Conflicts and Complementarities in EU Telecommunications*

In many countries infrastructure liberalization proceeded faster than the privatization of former state monopolies. Regulatory agencies, established to oversee the transition and safeguard the preconditions for competition, therefore monitor state-owned firms in addition to privately owned firms. The research on public-private firms has generated heterogeneous findings, with some pointing to th...

The future direction of EU Data Protection and privacy regulation

The information society has evolved in ways that were not anticipated when the existing Directive was adopted. Attitudes, behaviours and expectations concerning privacy are changing rapidly; the regulatory framework needs to keep pace if it is to retain its legitimacy. And these changes will only accelerate over the next 15 years. It is already clear that we need to fundamentally re-think the p...

EU regulation of endocrine disruptors: a missed opportunity.

The European Commission (EC) has missed a unique opportunity to develop a regulatory system that sets new standards in the protection against endocrine-disrupting chemicals. The proposed amendments to the European Union (EU) pesticide law and the criteria for the identification of endocrine disruptors that the EC published on June 15, 2016, after a delay of almost 3 years, ensure that hardly an...

EU law and regulation of private health insurance.

The influence of European Union (EU) law on private health insurance has not received as much attention as its impact on other parts of the health system (Hervey, 2007). Now is a good time to redress this relative neglect, as growing interest in private health insurance – in particular, its potential to relieve pressure on public budgets and enhance choice – raises questions about how best to c...